TCL Archive In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor January 6, 1989
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract March 16, 1984
